Tianmei Beverage Group Corporation Limited (ASX:TB8) Director and Company Secretary Appointment / Resignation
Tianmei Beverage Group Corporation Limited (ASX:TB8) announces the appointment of Jaylin Mao as a Non-Executive Director of the Company.
Tianmei Beverage Group Corporation Limited (ASX:TB8) announces the appointment of Jaylin Mao as a Non-Executive Director of the Company.
Tianmei Beverage Group Corporation Limited (ASX:TB8) is pleased to announce that it has commissioned a specialist independent blockchain solution company to design and implementation a new blockchain system to synergise and integrate with the existing enterprise systems.
The Board of Queensland Bauxite (ASX:QBL) is pleased to update its shareholders about the significant progress that its subsidiary company Medical Cannabis Limited (MCL) has recently made in executing its business plan and particularly in relation to MCL's Vitahemp food company and its impressive client list.
The Boards of Queensland Bauxite Limited (ASX:QBL) and Algae.Tec Ltd (ASX:AEB) are delighted to announce a significant Australian ground breaking agreement whereby AEB will exclusively license Medical Cannabis Limited's Low THC Delta 9 Cannabis cultivars from the unique Australian Cannabis seed bank owned by Medical Cannabis Limited.
Tianmei Beverage Group Corporation Limited (ASX:TB8) is pleased to advise that Mr Dong Xie was appointed as Non-Executive Director and Chairman of the Company. Mr Xie has more than 20 years' experience in investments and funds management.
Tianmei Beverage Group Corporation Limited (ASX:TB8) today provides an update on the Company's business growth strategy, ahead of its annual general meeting today.
In an article published on Forbes last week, Hemp-derived cannabidiol (CBD) is projected to be a billion-dollar market in just three years, according to a new report by Brightfield Group.